Molnupiravir As the COVID-19 Panacea: False Beliefs in Low- and Middle-income Countries
Overview
Overview
Journal
Pathog Glob Health
Specialties
Infectious Diseases
Microbiology
Public Health
Microbiology
Public Health
Date
2023 Jul 4
PMID
37401105
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.
Wu K, Guo Y, Xu T, Huang W, Guo D, Cao L Molecules. 2024; 29(10).
PMID: 38792173 PMC: 11124212. DOI: 10.3390/molecules29102312.
References
1.
Plata G
. The black market for covid-19 antiviral drugs. BMJ. 2022; 377:o1282.
DOI: 10.1136/bmj.o1282.
View
2.
Mizutani H, Koide T, Omura T, Ito K
. Interaction between warfarin and molnupiravir in a patient with coronavirus disease 2019 infection. J Family Med Prim Care. 2023; 11(11):7463-7465.
PMC: 10041292.
DOI: 10.4103/jfmpc.jfmpc_1387_22.
View
3.
Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E
. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 2022; 386(16):1532-1546.
PMC: 8908811.
DOI: 10.1056/NEJMoa2119451.
View
4.
Butler C, Hobbs F, Gbinigie O, Rahman N, Hayward G, Richards D
. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet. 2022; 401(10373):281-293.
PMC: 9779781.
DOI: 10.1016/S0140-6736(22)02597-1.
View
5.
Quan N, Anh N, Taylor-Robinson A
. The global COVID-19 vaccine surplus: tackling expiring stockpiles. Infect Dis Poverty. 2023; 12(1):21.
PMC: 10025780.
DOI: 10.1186/s40249-023-01070-7.
View